Long-Term Outcomes of Primary Trabeculectomy in Diabetic Patients without Retinopathy with Primary Angle-Closure Glaucoma

Purpose. To evaluate primary trabeculectomy with adjunctive mitomycin-C (MMC) in diabetic patients without retinopathy with primary angle-closure glaucoma (PACG). Design. This is a retrospective case series comparison. Participants. This retrospective trial compared outcomes of 88 eyes that underwen...

Full description

Saved in:
Bibliographic Details
Main Authors: Jian Liu, Miaomiao Zhang, Bin Li, Jianrong Wang
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2017/7947854
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562148776083456
author Jian Liu
Miaomiao Zhang
Bin Li
Jianrong Wang
author_facet Jian Liu
Miaomiao Zhang
Bin Li
Jianrong Wang
author_sort Jian Liu
collection DOAJ
description Purpose. To evaluate primary trabeculectomy with adjunctive mitomycin-C (MMC) in diabetic patients without retinopathy with primary angle-closure glaucoma (PACG). Design. This is a retrospective case series comparison. Participants. This retrospective trial compared outcomes of 88 eyes that underwent trabeculectomy in patients with diabetes mellitus (DM) without retinopathy and in 97 patients without DM. Methods. In this study, the intraocular pressure (IOP), visual acuity, visual field, and postoperative complications were compared between the two groups. Qualified surgical success is defined as an IOP between 6 and 18 mmHg with or without topical antiglaucoma medication. Results. After a follow-up of 5 years, the IOP decreased from a mean basal IOP of 27.8±7.3 mmHg to 15.0±5.6 mmHg in the DM group and from 27.3±6.0 mmHg to 12.4±5.3 mmHg in the control group. The mean number of antiglaucoma medications was 3.4±1.3 and 3.3±1.2 preoperatively (P=0.587) whereas it was 1.7±1.5 and 1.1±1.4 at the 5-year follow-up (P=0.049). The 5-year qualified surgical success rates were 42.9% and 65.4% for both groups (P=0.046; log-rank test). Encysted blebs were seen in 21 (23.9%) patients in the DM group and in 12 (12.4%) patients in the control group (P=0.041). Conclusion. PACG patients with DM without retinopathy undergoing primary trabeculectomy with MMC may have a lower long-term surgical survival rate compared with patients without DM.
format Article
id doaj-art-1dbd3a074fe946229248a1e850030247
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-1dbd3a074fe946229248a1e8500302472025-02-03T01:23:19ZengWileyJournal of Ophthalmology2090-004X2090-00582017-01-01201710.1155/2017/79478547947854Long-Term Outcomes of Primary Trabeculectomy in Diabetic Patients without Retinopathy with Primary Angle-Closure GlaucomaJian Liu0Miaomiao Zhang1Bin Li2Jianrong Wang3Department of Ophthalmology, The Second People’s Hospital of Jinan, No. 148 Jingyi Road, Jinan 250001, ChinaDepartment of Ophthalmology, The Second People’s Hospital of Jinan, No. 148 Jingyi Road, Jinan 250001, ChinaDepartment of Ophthalmology, The Second People’s Hospital of Jinan, No. 148 Jingyi Road, Jinan 250001, ChinaDepartment of Ophthalmology, The Second People’s Hospital of Jinan, No. 148 Jingyi Road, Jinan 250001, ChinaPurpose. To evaluate primary trabeculectomy with adjunctive mitomycin-C (MMC) in diabetic patients without retinopathy with primary angle-closure glaucoma (PACG). Design. This is a retrospective case series comparison. Participants. This retrospective trial compared outcomes of 88 eyes that underwent trabeculectomy in patients with diabetes mellitus (DM) without retinopathy and in 97 patients without DM. Methods. In this study, the intraocular pressure (IOP), visual acuity, visual field, and postoperative complications were compared between the two groups. Qualified surgical success is defined as an IOP between 6 and 18 mmHg with or without topical antiglaucoma medication. Results. After a follow-up of 5 years, the IOP decreased from a mean basal IOP of 27.8±7.3 mmHg to 15.0±5.6 mmHg in the DM group and from 27.3±6.0 mmHg to 12.4±5.3 mmHg in the control group. The mean number of antiglaucoma medications was 3.4±1.3 and 3.3±1.2 preoperatively (P=0.587) whereas it was 1.7±1.5 and 1.1±1.4 at the 5-year follow-up (P=0.049). The 5-year qualified surgical success rates were 42.9% and 65.4% for both groups (P=0.046; log-rank test). Encysted blebs were seen in 21 (23.9%) patients in the DM group and in 12 (12.4%) patients in the control group (P=0.041). Conclusion. PACG patients with DM without retinopathy undergoing primary trabeculectomy with MMC may have a lower long-term surgical survival rate compared with patients without DM.http://dx.doi.org/10.1155/2017/7947854
spellingShingle Jian Liu
Miaomiao Zhang
Bin Li
Jianrong Wang
Long-Term Outcomes of Primary Trabeculectomy in Diabetic Patients without Retinopathy with Primary Angle-Closure Glaucoma
Journal of Ophthalmology
title Long-Term Outcomes of Primary Trabeculectomy in Diabetic Patients without Retinopathy with Primary Angle-Closure Glaucoma
title_full Long-Term Outcomes of Primary Trabeculectomy in Diabetic Patients without Retinopathy with Primary Angle-Closure Glaucoma
title_fullStr Long-Term Outcomes of Primary Trabeculectomy in Diabetic Patients without Retinopathy with Primary Angle-Closure Glaucoma
title_full_unstemmed Long-Term Outcomes of Primary Trabeculectomy in Diabetic Patients without Retinopathy with Primary Angle-Closure Glaucoma
title_short Long-Term Outcomes of Primary Trabeculectomy in Diabetic Patients without Retinopathy with Primary Angle-Closure Glaucoma
title_sort long term outcomes of primary trabeculectomy in diabetic patients without retinopathy with primary angle closure glaucoma
url http://dx.doi.org/10.1155/2017/7947854
work_keys_str_mv AT jianliu longtermoutcomesofprimarytrabeculectomyindiabeticpatientswithoutretinopathywithprimaryangleclosureglaucoma
AT miaomiaozhang longtermoutcomesofprimarytrabeculectomyindiabeticpatientswithoutretinopathywithprimaryangleclosureglaucoma
AT binli longtermoutcomesofprimarytrabeculectomyindiabeticpatientswithoutretinopathywithprimaryangleclosureglaucoma
AT jianrongwang longtermoutcomesofprimarytrabeculectomyindiabeticpatientswithoutretinopathywithprimaryangleclosureglaucoma